Most lately, it has been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor acts like a scavenger https://frankc050qgw5.blogoscience.com/profile